HEALTHQUEST CAPITAL
HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry, including medical devices, biopharma, healthcare services, and healthcare IT
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Bascom Ventures
Bascom Ventures is a Venture Capital and Private Equity firm that specializes in investing across various sectors.
Current Employees Featured
Trit Garg
Trit Garg Vice President @ HealthQuest Capital Vice President
Todd A. Creech
Todd A. Creech Partner @ HealthQuest Capital Partner 2016-09-01
David Kabakoff
David Kabakoff Partner @ HealthQuest Capital Partner
Garheng Kong
Garheng Kong Founder and Managing Partner @ HealthQuest Capital Founder and Managing Partner 2012-07-01
Randy Scott
Randy Scott Partner @ HealthQuest Capital Partner 2012-01-01
Founder
Garheng Kong
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-27 | Nomad Health | HealthQuest Capital investment in Venture Round - Nomad Health | 105 M USD |
2022-02-16 | Magnolia Medical Technologies | HealthQuest Capital investment in Venture Round - Magnolia Medical Technologies | 46 M USD |
2021-11-29 | Lunit | HealthQuest Capital investment in Venture Round - Lunit | 61 M USD |
2021-09-09 | RareCyte | HealthQuest Capital investment in Series G - RareCyte | 24 M USD |
2021-06-02 | Thirty Madison | HealthQuest Capital investment in Series C - Thirty Madison | 140 M USD |
2021-01-17 | EverlyWell | HealthQuest Capital investment in Secondary Market - EverlyWell | 75 M USD |
2020-10-08 | TigerConnect | HealthQuest Capital investment in Series D - TigerConnect | 11.5 M USD |
2020-05-05 | Pulmonx | HealthQuest Capital investment in Series H - Pulmonx | 66 M USD |
2020-04-14 | Perspectum | HealthQuest Capital investment in Series B - Perspectum | 35.86 M USD |
2019-12-19 | RareCyte | HealthQuest Capital investment in Series F - RareCyte | 22 M USD |